Effect of Odanacatib on the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin after Administration in Healthy Postmenopausal Female Subjects.
Phase of Trial: Phase I
Latest Information Update: 25 Mar 2013
At a glance
- Drugs Odanacatib (Primary) ; Warfarin (Primary)
- Indications Postmenopausal osteoporosis; Thromboembolism
- Focus Pharmacokinetics
- 25 Mar 2013 New trial record
- 09 Mar 2013 Primary endpoint 'Area-under-the-drug-concentration-time-curve' has been met.
- 09 Mar 2013 Results presented at the 114th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.